BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37450666)

  • 21. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
    Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.
    Maiti P; Scott J; Sengupta D; Al-Gharaibeh A; Dunbar GL
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
    Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
    J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Wang J; Qi Q; Huang B; Chen A; Li X; Wang J
    Oncol Rep; 2016 Oct; 36(4):2160-8. PubMed ID: 27498786
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Kim HI; Hong SH; Ku JM; Kim MJ; Ju SW; Chang SW; Cheon C; Ko SG
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31936835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginkgolic acid induces apoptosis and autophagy of endometrial carcinoma cells via inhibiting PI3K/Akt/mTOR pathway in vivo and in vitro.
    Zhou L; Li S; Sun J
    Hum Exp Toxicol; 2021 Dec; 40(12):2156-2164. PubMed ID: 34132136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.
    Aeder SE; Martin PM; Soh JW; Hussaini IM
    Oncogene; 2004 Dec; 23(56):9062-9. PubMed ID: 15489897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.
    Liu L; Sun YH; An R; Cheng RJ; Li N; Zheng JH
    Kaohsiung J Med Sci; 2023 Aug; 39(8):779-788. PubMed ID: 37218642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.
    Li R; Chai L; Lei L; Guo R; Wen X
    Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
    Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
    Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
    Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
    Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuregulin-1 converts reactive astrocytes toward oligodendrocyte lineage cells via upregulating the PI3K-AKT-mTOR pathway to repair spinal cord injury.
    Ding Z; Dai C; Zhong L; Liu R; Gao W; Zhang H; Yin Z
    Biomed Pharmacother; 2021 Feb; 134():111168. PubMed ID: 33395598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression.
    Yang K; Luan L; Li X; Sun X; Yin J
    J Neurooncol; 2022 Jan; 156(1):123-137. PubMed ID: 34797524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
    Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
    Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.
    Wang J; Liu X; Hong Y; Wang S; Chen P; Gu A; Guo X; Zhao P
    J Exp Clin Cancer Res; 2017 Jul; 36(1):96. PubMed ID: 28716053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.